Key result
This review summarizes the etiology, management, rate versus rhythm control, stroke risk, and anticoagulation strategies for new-onset atrial fibrillation in critically ill patients.
This review provides a summary of the etiology and management strategies for new-onset atrial fibrillation in the intensive care unit.
Answers are grounded in this paper and cite their sources.
Offers a synthesis for new-onset AF management in critically ill patients; leaves open optimal anticoagulation and rhythm strategies pending prospective trials.
New-onset atrial fibrillation is a common problem in critically ill patients, with reported incidence ranging from 5% to 46%. It is associated with significant morbidity and mortality. The present review summarizes studies investigating new-onset atrial fibrillation conducted in the critical care setting, focusing on the etiology, management of the hemodynamically unstable patient, rate versus rhythm control, ischemic stroke risk and anticoagulation. Recommendations for an approach to management in the intensive care unit are drawn from the results of these studies.
No takes yet. Share an insight, caveat, or question.
Sibley et al. (2015) conducted a review in New-onset atrial fibrillation in critically ill patients. This review summarizes the etiology, management, rate versus rhythm control, stroke risk, and anticoagulation strategies for new-onset atrial fibrillation in critically ill patients.
Synapse has enriched 10 related papers. Consider them for comparative context: